Gregory C Critchfield
CIK 1191080 · View on SEC EDGAR ↗
First SEC filing: July 14, 2021 · Latest: July 14, 2021
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 28, 2009 | MYGN | S | 38,702 | $30.75 | $1,190,086 | 129,546 Direct | -23.00% | Disposed | -89.5% (price as of 2026-08-20) |
| Aug. 28, 2009 | MYGN | S | 7,980 | $30.75 | $245,385 | 129,546 Direct | -5.80% | Disposed | -89.5% (price as of 2026-08-20) |
| Feb. 3, 2009 | MYGN | S 10b5-1 | 20,000 | $84.50 | $1,690,000 | 62,506 Direct | -24.24% | Disposed | -92.4% (price as of 2026-08-20) |
| Jan. 28, 2009 | MYGN | S 10b5-1 | 20,000 | $74.50 | $1,490,000 | 48,506 Direct | -29.19% | Disposed | -91.3% (price as of 2026-08-20) |
| Sept. 17, 2008 | MYGN | S | 1 | $66.08 | $66 | 53,121 Direct | 0.00% | Disposed | -90.2% (price as of 2026-08-20) |
| Sept. 17, 2008 | MYGN | S | 32,379 | $66.08 | $2,139,604 | 53,121 Direct | -37.87% | Disposed | -90.2% (price as of 2026-08-20) |
| Sept. 26, 2007 | MYGN | S 10b5-1 | 9,342 | $50.00 | $467,100 | 45,815 Direct | -16.94% | Disposed | -87.1% (price as of 2026-08-20) |
| Sept. 25, 2007 | MYGN | S 10b5-1 | 18,658 | $50.00 | $932,900 | 45,815 Direct | -28.94% | Disposed | -87.1% (price as of 2026-08-20) |
| April 17, 2006 | MYGN | S 10b5-1 | 35,556 | $24.55 | $872,900 | 43,720 Direct | -44.85% | Disposed | -73.7% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| July 10, 2026 | SERA | Stock Option (right to buy) | Class A Common Stock (2,452) | $1.97 | July 10, 2036 | 2,452 | Acquired |
| July 10, 2026 | SERA | Stock Option (right to buy) | Class A Common Stock (34,494) | $1.97 | July 10, 2036 | 34,494 | Acquired |
| June 5, 2025 | SERA | Stock Option (right to buy) | Class A Common Stock (25,000) | $1.60 | June 5, 2035 | 25,000 | Acquired |
| July 19, 2021 | SERA | Series D Preferred Stock | Class A Common Stock (28,730) | — | — | 28,730 | Disposed |
| July 19, 2021 | SERA | Series C-1 Preferred Stock | Class A Common Stock (4,727) | — | — | 4,727 | Disposed |
| July 19, 2021 | SERA | Series B-2 Preferred Stock | Class A Common Stock (11,880) | — | — | 11,880 | Disposed |
| July 19, 2021 | SERA | Series B-1 Preferred Stock | Class A Common Stock (5,253) | — | — | 5,253 | Disposed |
| July 19, 2021 | SERA | Series A-2 Preferred Stock | Class A Common Stock (34,383) | — | — | 34,383 | Disposed |
| Sept. 15, 2009 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (89,139) | $30.34 | Sept. 15, 2019 | 89,139 | Acquired |
| Sept. 15, 2009 | MYGN | Incentive Stock Option (right to buy) | Common Stock (3,861) | $30.34 | Sept. 15, 2019 | 3,861 | Acquired |
| Aug. 28, 2009 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (38,702) | $8.86 | April 20, 2010 | 38,702 | Disposed |
| Aug. 28, 2009 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (7,980) | $8.86 | April 20, 2010 | 7,980 | Disposed |
| May 8, 2009 | MYGN | Incentive Stock Option (right to buy) | Common Stock (2,636) | $12.53 | April 20, 2010 | 2,636 | Disposed |
| Feb. 18, 2009 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (58,827) | $85.20 | Feb. 18, 2019 | 58,827 | Acquired |
| Feb. 18, 2009 | MYGN | Incentive Stock Option (right to buy) | Common Stock (1,173) | $85.20 | Feb. 18, 2019 | 1,173 | Acquired |
| Feb. 3, 2009 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (20,000) | $16.64 | Sept. 8, 2014 | 20,000 | Disposed |
| Jan. 29, 2009 | MYGN | Incentive Stock Option (right to buy) | Common Stock (14,000) | $4.78 | June 17, 2009 | 14,000 | Disposed |
| Jan. 28, 2009 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (20,000) | $16.64 | Sept. 8, 2014 | 20,000 | Disposed |
| Sept. 17, 2008 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (1) | $12.54 | Sept. 9, 2013 | 1 | Disposed |
| Sept. 17, 2008 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (32,379) | $12.54 | Sept. 9, 2013 | 32,379 | Disposed |
| Sept. 10, 2008 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (65,000) | $64.88 | Sept. 10, 2018 | 65,000 | Acquired |
| Feb. 28, 2008 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (62,338) | $37.56 | Feb. 28, 2018 | 62,338 | Acquired |
| Feb. 28, 2008 | MYGN | Incentive Stock Option (right to buy) | Common Stock (2,662) | $37.56 | Feb. 28, 2018 | 2,662 | Acquired |
| Jan. 25, 2008 | MYGN | Incentive Stock Option (right to buy) | Common Stock (9,322) | $7.03 | July 31, 2008 | 9,322 | Disposed |
| Dec. 20, 2007 | MYGN | Incentive Stock Option (right to buy) | Common Stock (4,900) | $7.03 | July 31, 2008 | 4,900 | Disposed |
| Sept. 26, 2007 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (50,000) | $51.08 | Sept. 26, 2017 | 50,000 | Acquired |
| Sept. 26, 2007 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (9,342) | $4.78 | June 17, 2009 | 9,342 | Disposed |
| Sept. 25, 2007 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (18,658) | $4.78 | June 17, 2009 | 18,658 | Disposed |
| Feb. 21, 2007 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (31,096) | $34.43 | Feb. 21, 2017 | 31,096 | Acquired |
| Feb. 21, 2007 | MYGN | Incentive Stock Option (right to buy) | Common Stock (2,904) | $34.43 | Feb. 21, 2017 | 2,904 | Acquired |
| Sept. 6, 2006 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (32,000) | $25.57 | Sept. 6, 2016 | 32,000 | Acquired |
| April 17, 2006 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (35,556) | $7.03 | July 31, 2008 | 35,556 | Disposed |
| Feb. 16, 2006 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (27,902) | $24.40 | Feb. 16, 2016 | 27,902 | Acquired |
| Feb. 16, 2006 | MYGN | Incentive Stock Option (right to buy) | Common Stock (4,098) | $24.40 | Feb. 16, 2016 | 4,098 | Acquired |
| Sept. 14, 2005 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (20,548) | $20.56 | Sept. 14, 2015 | 20,548 | Acquired |
| Sept. 14, 2005 | MYGN | Incentive Stock Option (right to buy) | Common Stock (19,452) | $20.56 | Sept. 14, 2015 | 19,452 | Acquired |
| Feb. 17, 2005 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (40,480) | $22.12 | Feb. 17, 2015 | 40,480 | Acquired |
| Feb. 17, 2005 | MYGN | Incentive Stock Option (right to buy) | Common Stock (4,520) | $22.12 | Feb. 17, 2015 | 4,520 | Acquired |
| Sept. 8, 2004 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (40,000) | $16.64 | Sept. 8, 2014 | 40,000 | Acquired |
| Feb. 19, 2004 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (24,108) | $16.97 | Feb. 19, 2014 | 24,108 | Acquired |
| Feb. 19, 2004 | MYGN | Incentive Stock Option (right to buy) | Common Stock (5,892) | $16.97 | Feb. 19, 2014 | 5,892 | Acquired |
| Sept. 9, 2003 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (32,379) | $12.54 | Sept. 9, 2013 | 32,379 | Acquired |
| Sept. 9, 2003 | MYGN | Incentive Stock Option (right to buy) | Common Stock (2,621) | $12.54 | Sept. 9, 2013 | 2,621 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 12 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| July 14, 2021 | SERA | Class A Common Stock | 79,140 | Direct |
| July 14, 2021 | SERA | Class A Common Stock | 630,832 | Indirect |
| July 14, 2021 | SERA | Series A-2 Preferred Stock→ Class A Common Stock (34,383) | 34,383 | Direct |
| July 14, 2021 | SERA | Series B-1 Preferred Stock→ Class A Common Stock (5,253) | 5,253 | Direct |
| July 14, 2021 | SERA | Series B-2 Preferred Stock→ Class A Common Stock (11,880) | 11,880 | Direct |
| July 14, 2021 | SERA | Series C-1 Preferred Stock→ Class A Common Stock (4,727) | 4,727 | Direct |
| July 14, 2021 | SERA | Series D Preferred Stock→ Class A Common Stock (28,730) | 28,730 | Direct |
| July 14, 2021 | SERA | Stock Option (right to buy)→ Class A Common Stock (300,610) | 300,610 | Direct |
| July 14, 2021 | SERA | Stock Option (right to buy)→ Class A Common Stock (462,338) | 462,338 | Direct |
| July 14, 2021 | SERA | Stock Option (right to buy)→ Class A Common Stock (98,330) | 98,330 | Direct |
| July 14, 2021 | SERA | Warrant (right to buy)→ Class A Common Stock (4,412) | 4,412 | Indirect |
| July 14, 2021 | SERA | Warrant (right to buy)→ Class A Common Stock (4,412) | 4,412 | Indirect |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
MYGN
M.D. President, Myriad Genetic Laboratories, Inc.| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2007 | $465,478 | $350,761 | — | $378,292 | — | — | $9,084 | $1,203,615 |
| 2002 | — | — | — | — | — | — | — | — |
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2023 | $313,023 | — | $231,384 | $243,017 | $131,400 | — | $594,025 | $1,512,849 |
| 2022 | $584,000 | — | — | $989,624 | $206,736 | — | — | $1,780,360 |
| 2021 | $500,100 | — | — | $453,519 | $275,000 | — | — | $1,228,619 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.